Baseline gadolinium-enhancing MRI lesions failed to predict the on-study relapse rate (whereas the prestudy relapse rate did), and baseline lesion load on T2-weighted MRI had minimal predictive ...

“Contrast-enhanced MRI is a key diagnostic tool and particularly ... development program is a key step in exploring a reduced gadolinium dose for patients in clinical practice while ...

“The QUANTI clinical development programme is a key step in exploring a reduced gadolinium dose for patients in clinical practice while demonstrating similar efficacy to the trial comparators. This is ...